Myriad Genetics | MYGN - Market Capitalization

Stock Price
5.25
Daily Change
-0.05 -0.94%
Monthly
-19.48%
Yearly
-58.76%
Q1 Forecast
5.45

Myriad Genetics reported $475.4M in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agilent USD 41.49B 8.93B Sep/2025
Becton, Dickinson and Co. USD 53.65B 4.28B Sep/2025
Bio-Rad Laboratories USD 7.61B 1.08B Sep/2025
Bruker USD 4.93B 1.31B Sep/2025
Danaher USD 161.7B 29.34B Dec/2025
Exact Sciences USD 10.36B 334M Sep/2025
Hologic USD 16.62B 1.67B Dec/2025
Illumina USD 21.33B 7.24B Feb/2026
J&J USD 500.24B 67.44B Dec/2025
Mettler Toledo International USD 29.48B 4.19B Feb/2026
Myriad Genetics USD 494M 316M Jun/2025
Quest Diagnostics USD 21.31B 1.26B Sep/2025
Quidel USD 1.92B 28M Sep/2025
Repligen USD 7.52B 532M Sep/2025
Revvity USD 13.23B 3.47B Feb/2026
Standard Biotools USD 521M 24M Feb/2026
Thermo Fisher Scientific USD 217.7B 42.4B Dec/2025
Veracyte USD 2.7B 584M Sep/2025
Waters USD 17.36B 3.61B Sep/2025